【China Chemical & Pharmaceutical Co., Ltd. Biotech】Q1 2026 EPS NT$1.64
NQ Score
0/100
N1 Content Completeness
2
AI Summary (NQ-processed)
China Chemical & Pharmaceutical Co., Ltd. Biotech (1762) announced strong financial results for Q1 2026, achieving revenue of NT$361 million, net profit of NT$91 million, and a high earnings per share (EPS) of NT$1.64, indicating strong profitability and growth.